Proton Partners has agreed to acquire the Gulf International Cancer Centre in Abu Dhabi as a part of its plan to establish the first proton beam therapy treatment centre in the United Arab Emirates (UAE).
Under the sale-and-purchase agreement, the cancer centre will be acquired from Mediclinic Middle East and the Al Noor Hospitals Group, a part of Mediclinic International.
The acquisition of the Gulf International Cancer Centre will allow Proton Partners to provide proton beam therapy treatment in addition to conventional cancer treatments.
Proton Partners International CEO Mike Moran MBE said: “There is a growing need for proton beam therapy treatment around the world and no centres currently offer this in the Middle East.
“The treatment is transforming the lives of many thousands of cancer patients. We are delighted that the acquisition of the Gulf International Cancer Centre (GICC) means the creation of the first proton beam therapy centre in the United Arab Emirates is fast becoming a reality.”
The new Abu Dhabi Proton Centre (ADPC) will have Proton Partners, part of Dubai-based Alfardan Group, The First Investor and the Kuwaiti-based Al Sayer Group as joint investors.
The centre is located on a site provided by SBK Holding.